NCT01657370 A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007) Status COMPLETED Phase PHASE2
NCT01653522 The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine Status WITHDRAWN Phase NA
NCT01637662 Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow Status COMPLETED Phase NA
NCT01613248 A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006) Status COMPLETED Phase PHASE2
NCT01534806 Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department Status WITHDRAWN Phase PHASE4
NCT01532830 Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine Status COMPLETED Phase NA
NCT01513291 A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020) Status COMPLETED Phase PHASE2
NCT01507610 Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01501045 Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM) Status COMPLETED Phase NA
NCT01488110 Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine Status TERMINATED Phase NA
NCT01470352 Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention Status COMPLETED Phase NA
NCT01450995 Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex Status COMPLETED Phase PHASE4
NCT01445067 Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition Status COMPLETED Phase PHASE1
NCT01430442 Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine Status COMPLETED Phase PHASE2
NCT01407861 Aerobic Endurance Training vs. Relaxation Training in Patients With Migraine Status COMPLETED Phase NA